Showing results (171-180 of 217) with videos related to

Sort By:
Pageof 22
Antimicrobial Agents and Chemotherapy|November 26, 2014
Histone methyltransferase inhibitors are orally bioavailable, fast-acting molecules with activity against different species causing malaria in humansNicholas A Malmquist, Sandeep Sundriyal, Joachim Caron, et al.
The Journal of Investigative Dermatology|January 24, 2016
Neutrophils Self-Regulate Immune Complex-Mediated Cutaneous Inflammation through CXCL2Jackson LiangYao Li, Chun Hwee Lim, Fen Wei Tay, et al.
Human Vaccines & Immunotherapeutics|May 5, 2026
NVX-CoV2372, monovalent mRNA and bivalent mRNA vaccines elicit broadly cross-reactive antibodies against emerging SARS-CoV-2 variantsXuan Ying Poh, Shirley Y Y Mah, Aileen Y Y Yeoh, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|June 30, 2024
Imprinting of IgA responses in previously infected individuals receiving bivalent mRNA vaccines (WT and BA.4/BA.5 or WT and BA.1)Yun Shan Goh, Siew-Wai Fong, Pei Xiang Hor, et al.
Nature Communications|January 18, 2024
Longitudinal single cell atlas identifies complex temporal relationship between type I interferon response and COVID-19 severityQuy Xiao Xuan Lin, Deepa Rajagopalan, Akshamal M Gamage, et al.
Nature Microbiology|September 20, 2016
UDP-galactose and acetyl-CoA transporters as Plasmodium multidrug resistance genesMichelle Yi-Xiu Lim, Gregory LaMonte, Marcus C S Lee, et al.
Nature Communications|October 20, 2025
Mosquito salivary sialokinin reduces monocyte activation and chikungunya virus-induced inflammation via neurokinin receptorsSiew-Wai Fong, Jeslin J L Tan, Vaishnavi Sridhar, et al.
The Lancet. Microbe|March 29, 2021
Dynamics of SARS-CoV-2 neutralising antibody responses and duration of immunity: a longitudinal studyWan Ni Chia, Feng Zhu, Sean Wei Xiang Ong, et al.
Pageof 22